GenMont Biotech Incorporation (TPE:3164)
Taiwan · Delayed Price · Currency is TWD 16.95
+0.25 (1.50%)
Oct 8, 2026, 1:30 PM CST
TPE:3164 Market Cap
TPE:3164 has a market cap or net worth of 1.46 billion as of October 9, 2026. It is the 31,094th most valuable company in the world and the 1,849th biggest in Taiwan. Its market cap has decreased by 12.53% in one year.
Market Cap
1.46B
Enterprise Value
1.35B
Revenue
382.11M
Global Rank
Country Rank
#1,849 Taiwan
PE Ratio
21.16
ChartMarket Cap Chart
Since May 8, 2006, TPE:3164's market cap has increased from 899.18M to 1.46B, an increase of 62.13%. That is a compound annual growth rate of 2.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.46B | -7.63% |
| Dec 31, 2025 | 1.58B | -9.68% |
| Dec 31, 2024 | 1.75B | -18.22% |
| Dec 29, 2023 | 2.14B | 4.39% |
| Dec 30, 2022 | 2.05B | -2.67% |
| Dec 30, 2021 | 2.10B | 9.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunny Pharmtech | 1.82B |
| U-Neuron Biomedical | 1.79B |
| Synbio Tech | 1.73B |
| TaiRx | 1.64B |
| Andros Pharmaceuticals Co.,Ltd | 1.61B |
| Greenyn Biotechnology | 1.56B |
| Advagene Biopharma | 1.48B |
| Taiwan Bio Therapeutics | 1.37B |